Cargando…

Mapping N- to C-terminal allosteric coupling through disruption of a putative CD74 activation site in D-dopachrome tautomerase

The macrophage migration inhibitory factor (MIF) protein family consists of MIF and D-dopachrome tautomerase (also known as MIF-2). These homologs share 34% sequence identity while maintaining nearly indistinguishable tertiary and quaternary structure, which is likely a major contributor to their ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Emily, Widjaja, Vinnie, Kyro, Gregory, Allen, Brandon, Das, Pragnya, Prahaladan, Varsha M., Bhandari, Vineet, Lolis, Elias J., Batista, Victor S., Lisi, George P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208890/
https://www.ncbi.nlm.nih.gov/pubmed/37080391
http://dx.doi.org/10.1016/j.jbc.2023.104729
_version_ 1785046764574736384
author Chen, Emily
Widjaja, Vinnie
Kyro, Gregory
Allen, Brandon
Das, Pragnya
Prahaladan, Varsha M.
Bhandari, Vineet
Lolis, Elias J.
Batista, Victor S.
Lisi, George P.
author_facet Chen, Emily
Widjaja, Vinnie
Kyro, Gregory
Allen, Brandon
Das, Pragnya
Prahaladan, Varsha M.
Bhandari, Vineet
Lolis, Elias J.
Batista, Victor S.
Lisi, George P.
author_sort Chen, Emily
collection PubMed
description The macrophage migration inhibitory factor (MIF) protein family consists of MIF and D-dopachrome tautomerase (also known as MIF-2). These homologs share 34% sequence identity while maintaining nearly indistinguishable tertiary and quaternary structure, which is likely a major contributor to their overlapping functions, including the binding and activation of the cluster of differentiation 74 (CD74) receptor to mediate inflammation. Previously, we investigated a novel allosteric site, Tyr99, that modulated N-terminal catalytic activity in MIF through a “pathway” of dynamically coupled residues. In a comparative study, we revealed an analogous allosteric pathway in MIF-2 despite its unique primary sequence. Disruptions of the MIF and MIF-2 N termini also diminished CD74 activation at the C terminus, though the receptor activation site is not fully defined in MIF-2. In this study, we use site-directed mutagenesis, NMR spectroscopy, molecular simulations, in vitro and in vivo biochemistry to explore the putative CD74 activation region of MIF-2 based on homology to MIF. We also confirm its reciprocal structural coupling to the MIF-2 allosteric site and N-terminal enzymatic site. Thus, we provide further insight into the CD74 activation site of MIF-2 and its allosteric coupling for immunoregulation.
format Online
Article
Text
id pubmed-10208890
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-102088902023-05-26 Mapping N- to C-terminal allosteric coupling through disruption of a putative CD74 activation site in D-dopachrome tautomerase Chen, Emily Widjaja, Vinnie Kyro, Gregory Allen, Brandon Das, Pragnya Prahaladan, Varsha M. Bhandari, Vineet Lolis, Elias J. Batista, Victor S. Lisi, George P. J Biol Chem Research Article The macrophage migration inhibitory factor (MIF) protein family consists of MIF and D-dopachrome tautomerase (also known as MIF-2). These homologs share 34% sequence identity while maintaining nearly indistinguishable tertiary and quaternary structure, which is likely a major contributor to their overlapping functions, including the binding and activation of the cluster of differentiation 74 (CD74) receptor to mediate inflammation. Previously, we investigated a novel allosteric site, Tyr99, that modulated N-terminal catalytic activity in MIF through a “pathway” of dynamically coupled residues. In a comparative study, we revealed an analogous allosteric pathway in MIF-2 despite its unique primary sequence. Disruptions of the MIF and MIF-2 N termini also diminished CD74 activation at the C terminus, though the receptor activation site is not fully defined in MIF-2. In this study, we use site-directed mutagenesis, NMR spectroscopy, molecular simulations, in vitro and in vivo biochemistry to explore the putative CD74 activation region of MIF-2 based on homology to MIF. We also confirm its reciprocal structural coupling to the MIF-2 allosteric site and N-terminal enzymatic site. Thus, we provide further insight into the CD74 activation site of MIF-2 and its allosteric coupling for immunoregulation. American Society for Biochemistry and Molecular Biology 2023-04-18 /pmc/articles/PMC10208890/ /pubmed/37080391 http://dx.doi.org/10.1016/j.jbc.2023.104729 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Chen, Emily
Widjaja, Vinnie
Kyro, Gregory
Allen, Brandon
Das, Pragnya
Prahaladan, Varsha M.
Bhandari, Vineet
Lolis, Elias J.
Batista, Victor S.
Lisi, George P.
Mapping N- to C-terminal allosteric coupling through disruption of a putative CD74 activation site in D-dopachrome tautomerase
title Mapping N- to C-terminal allosteric coupling through disruption of a putative CD74 activation site in D-dopachrome tautomerase
title_full Mapping N- to C-terminal allosteric coupling through disruption of a putative CD74 activation site in D-dopachrome tautomerase
title_fullStr Mapping N- to C-terminal allosteric coupling through disruption of a putative CD74 activation site in D-dopachrome tautomerase
title_full_unstemmed Mapping N- to C-terminal allosteric coupling through disruption of a putative CD74 activation site in D-dopachrome tautomerase
title_short Mapping N- to C-terminal allosteric coupling through disruption of a putative CD74 activation site in D-dopachrome tautomerase
title_sort mapping n- to c-terminal allosteric coupling through disruption of a putative cd74 activation site in d-dopachrome tautomerase
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208890/
https://www.ncbi.nlm.nih.gov/pubmed/37080391
http://dx.doi.org/10.1016/j.jbc.2023.104729
work_keys_str_mv AT chenemily mappingntocterminalallostericcouplingthroughdisruptionofaputativecd74activationsiteinddopachrometautomerase
AT widjajavinnie mappingntocterminalallostericcouplingthroughdisruptionofaputativecd74activationsiteinddopachrometautomerase
AT kyrogregory mappingntocterminalallostericcouplingthroughdisruptionofaputativecd74activationsiteinddopachrometautomerase
AT allenbrandon mappingntocterminalallostericcouplingthroughdisruptionofaputativecd74activationsiteinddopachrometautomerase
AT daspragnya mappingntocterminalallostericcouplingthroughdisruptionofaputativecd74activationsiteinddopachrometautomerase
AT prahaladanvarsham mappingntocterminalallostericcouplingthroughdisruptionofaputativecd74activationsiteinddopachrometautomerase
AT bhandarivineet mappingntocterminalallostericcouplingthroughdisruptionofaputativecd74activationsiteinddopachrometautomerase
AT loliseliasj mappingntocterminalallostericcouplingthroughdisruptionofaputativecd74activationsiteinddopachrometautomerase
AT batistavictors mappingntocterminalallostericcouplingthroughdisruptionofaputativecd74activationsiteinddopachrometautomerase
AT lisigeorgep mappingntocterminalallostericcouplingthroughdisruptionofaputativecd74activationsiteinddopachrometautomerase